These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 14759641

  • 1. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C.
    J Neurol Sci; 2004 Mar 15; 218(1-2):103-8. PubMed ID: 14759641
    [Abstract] [Full Text] [Related]

  • 2. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH, Sajko MC, Rot U.
    Clin Neurol Neurosurg; 2013 Dec 15; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.
    Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H.
    Neurol Res; 2012 Nov 15; 34(9):854-8. PubMed ID: 22979982
    [Abstract] [Full Text] [Related]

  • 4. Amantadine influences cognitive processing in patients with multiple sclerosis.
    Sailer M, Heinze HJ, Schoenfeld MA, Hauser U, Smid HG.
    Pharmacopsychiatry; 2000 Jan 15; 33(1):28-37. PubMed ID: 10721881
    [Abstract] [Full Text] [Related]

  • 5. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M, Onesti E, Tomassini V, Conte A, Gupta S, Gilio F, Pantano P, Pozzilli C, Inghilleri M.
    Clin Neuropharmacol; 2009 Jan 15; 32(1):41-7. PubMed ID: 18978501
    [Abstract] [Full Text] [Related]

  • 6. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.
    Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M.
    Neurology; 2005 Apr 12; 64(7):1267-9. PubMed ID: 15824361
    [Abstract] [Full Text] [Related]

  • 7. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M, Gargante MP, Cristaldi E, Colonna V, Messano M, Koverech A, Neri S, Vacante M, Cammalleri L, Motta M.
    Arch Gerontol Geriatr; 2008 Apr 12; 46(2):181-90. PubMed ID: 17658628
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
    Youle M, Osio M, ALCAR Study Group.
    HIV Med; 2007 May 12; 8(4):241-50. PubMed ID: 17461852
    [Abstract] [Full Text] [Related]

  • 9. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
    Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM.
    J Neurol; 2002 Aug 12; 249(8):983-7. PubMed ID: 12195441
    [Abstract] [Full Text] [Related]

  • 10. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
    Ashtari F, Fatehi F, Shaygannejad V, Chitsaz A.
    Neurol Neurochir Pol; 2009 Aug 12; 43(5):428-32. PubMed ID: 20054744
    [Abstract] [Full Text] [Related]

  • 11. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
    Lappin MS, Lawrie FW, Richards TL, Kramer ED.
    Altern Ther Health Med; 2003 Aug 12; 9(4):38-48. PubMed ID: 12868251
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
    Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, Krysko K, Rutatangwa A, Auvray C, Aljarallah S, Jin C, Mowry E, McCulloch C, Waubant E.
    Lancet Neurol; 2021 Jan 12; 20(1):38-48. PubMed ID: 33242419
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM, Dackis C, Lynch KG, Pettinati H, Tirado C, Gariti P, Sparkman T, Atzram M, O'Brien CP.
    Drug Alcohol Depend; 2006 Nov 08; 85(2):129-37. PubMed ID: 16697124
    [Abstract] [Full Text] [Related]

  • 14. Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
    Foroughipour M, Bahrami Taghanaki HR, Saeidi M, Khazaei M, Sasannezhad P, Shoeibi A.
    Acupunct Med; 2013 Mar 08; 31(1):27-30. PubMed ID: 23151355
    [Abstract] [Full Text] [Related]

  • 15. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M, French Modafinil Study Group.
    Neurology; 2005 Apr 12; 64(7):1139-43. PubMed ID: 15824337
    [Abstract] [Full Text] [Related]

  • 16. Carnitine for fatigue in multiple sclerosis.
    Tejani AM, Wasdell M, Spiwak R, Rowell G, Nathwani S.
    Cochrane Database Syst Rev; 2010 Feb 17; (2):CD007280. PubMed ID: 20166093
    [Abstract] [Full Text] [Related]

  • 17. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
    Bruce J, Hancock L, Roberg B, Brown A, Henkelman E, Lynch S.
    Cogn Behav Neurol; 2012 Sep 17; 25(3):107-14. PubMed ID: 22960434
    [Abstract] [Full Text] [Related]

  • 18. Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS).
    Benito-León J, Martínez-Martín P, Frades B, Martínez-Ginés ML, de Andrés C, Meca-Lallana JE, Antigüedad AR, Huete-Antón B, Rodríguez-García E, Ruiz-Martínez J.
    Mult Scler; 2007 Jun 17; 13(5):645-51. PubMed ID: 17548445
    [Abstract] [Full Text] [Related]

  • 19. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue.
    Theal JJ, Toosi MN, Girlan L, Heslegrave RJ, Huet PM, Burak KW, Swain M, Tomlinson GA, Heathcote EJ.
    Hepatology; 2005 Jun 17; 41(6):1305-12. PubMed ID: 15915460
    [Abstract] [Full Text] [Related]

  • 20. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
    Ciacci C, Peluso G, Iannoni E, Siniscalchi M, Iovino P, Rispo A, Tortora R, Bucci C, Zingone F, Margarucci S, Calvani M.
    Dig Liver Dis; 2007 Oct 17; 39(10):922-8. PubMed ID: 17693145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.